Martin R Keene1, Ian M Heslop2, Sabe S Sabesan2, Beverley D Glass2. 1. College of Medicine and Dentistry, James Cook University, Townsville, 4811, Australia. Electronic address: martin.keene@jcu.edu.au. 2. College of Medicine and Dentistry, James Cook University, Townsville, 4811, Australia.
Abstract
BACKGROUND AND PURPOSE: Complementary and alternative medicine (CAM) use in cancer is increasing. The purpose of this study was to systematically review the literature to determine demographic profiles and prevalence and reasons for use in cancer patients. METHODS: In this systematic review, the databases OVID, PubMed, and Scopus were searched for studies on CAM use in cancer between 2009 and June 2018. RESULTS: The results showed that an average of 51% of cancer patients used CAM. Common independent demographic characteristics associated with CAM use were younger, female cancer patients, having higher education, earning a higher income and having previously used CAM. Frequent reasons for use, grouped into themes were shown to be to influence their cancer and general health and to treat complications of the cancer or therapy. CONCLUSION: The review provides an insight and will serve to better inform health professionals on how this population is using CAM.
BACKGROUND AND PURPOSE: Complementary and alternative medicine (CAM) use in cancer is increasing. The purpose of this study was to systematically review the literature to determine demographic profiles and prevalence and reasons for use in cancerpatients. METHODS: In this systematic review, the databases OVID, PubMed, and Scopus were searched for studies on CAM use in cancer between 2009 and June 2018. RESULTS: The results showed that an average of 51% of cancerpatients used CAM. Common independent demographic characteristics associated with CAM use were younger, female cancerpatients, having higher education, earning a higher income and having previously used CAM. Frequent reasons for use, grouped into themes were shown to be to influence their cancer and general health and to treat complications of the cancer or therapy. CONCLUSION: The review provides an insight and will serve to better inform health professionals on how this population is using CAM.
Authors: Ellen Krueger; Ekin Secinti; Catherine E Mosher; Patrick V Stutz; Andrea A Cohee; Shelley A Johns Journal: Cancer Nurs Date: 2021 Nov-Dec 01 Impact factor: 2.592
Authors: John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki Journal: Evid Based Complement Alternat Med Date: 2021-05-17 Impact factor: 2.650
Authors: Claudia Canella; Michael Mikolasek; Matthias Rostock; Matthias Guckenberger; Josef Jenewein; Esther Linka; Claudia Six; Sarah Stoll; Roger Stupp; Claudia M Witt Journal: BMC Cancer Date: 2020-05-24 Impact factor: 4.430